Implanet: CE Mark for JAZZ Band Passer
Elizabeth Hofheinz, M.P.H., M.Ed. • Mon, November 6th, 2017
Let the European marketing begin...spine and knee company Implanet, based near Bordeaux, France, has announced the receipt of CE regulatory clearance to market the new JAZZ Passer, a product devoted to posterior fixation in spine surgery.
Ludovic Lastennet, CEO of Implanet, said in the October 19, 2017 news release. “This innovation will accelerate the adoption of JAZZ technology by new European surgeons. This highly dynamic market is driven by France and Germany, regions where we are active, notably in the high potential adult degenerative bone disorder segment. At the recent Eurospine conference in Dublin, we saw enthusiasm for our solution from health professionals and surgeons. We were able to show, during a thematic evening with more than 50 participants and throughout this conference, how easy to use our latest innovations are.”
Lastennet told OTW, “JAZZ Band Passer is a brand new product designed by our research and development team that had to pass all regulatory steps. Like all new orthopaedic implants, JAZZ Band Passer from Implanet was submitted both for FDA 510(k) approval and CE Marking at the same time. We received the 510(k) approval from FDA end of September and the CE Marking in mid-October.”
“JAZZ Band passer is composed of a new JAZZ Band specially designed to be used with our new range of JAZZ Passers. This new product has been designed on surgeons request, to ease the surgical gesture and provide to surgeons an instruments to pass the Band around the anatomy of the patient. We believe that this new design will help the conversion of new surgeons to our technology.”